Point72 Asset Management
KALV icon

Point72 Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History

Point72 Asset Management’s Portfolio KALV Stock Details KALV Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$36.9M Buy
2022
Q4 		– Sell
2022
Q3 		$839K Buy
2019
Q4 		– Sell
2019
Q3 		$1.01M Sell
2019
Q2 		$3.61M Buy